Rokitamycin: Bacterial Resistance to a 16-Membered Ring Macrolide Differs from that to 14- and 15-Membered Ring Macrolides

References

• Washington JA, Wilson WR. Erythromycin a microbial and clinical perspective after 30 years of clinical use. Mayo Clinic Proc 1985; 60: 271–278.
   PubMed Web of Science ®Google Scholar
• Bryskier A, Agouridas C, Gasc J-C. Classification of macrolides antibiotics. In: Bryskier AJ, Butzler J-P, Neu HC, Tulkens PM (eds) Macrolides: chemistry, pharmacology and clinical uses. Oxford: Arnette Blackwell, 1993: 5-66.
   Google Scholar
• Jones WF, Nichols RL, Finland M. Development of resistance and cross-resistance in-vitro to erythromycin, car-bomycin, spiramycin, oleandomycin and streptogramin. Proc Soc Exper Biol Med 1956; 93: 388–392.
   PubMed Web of Science ®Google Scholar
• Leclercq R, Courvalin P. Mechanisms of resistance to macrolides and functionally related antibiotics. In: Bryskier AJ, Butzler JP, Neu HC, Tulkens PM (eds) Macrolides: chemistry, pharmacology and clinical uses. Oxford: Arnette Blackwell, 1993: 115-123.
   Google Scholar
• Leclercq R, Courvalin P. Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob Agents Chemother 1991; 35: 1273–1276.
   PubMed Web of Science ®Google Scholar
• Fernandes PB, Baker WR, Freiberg LA, Hardy DJ, McDonald EJ. New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolide-lin-cosamide-streptogramin B resistance. Antimicrob Agents Chemother 1989; 33: 78–81.
   PubMed Web of Science ®Google Scholar
• Klugman KP, Capper T, Widdowson CA, Koornhof HJ, Moser W. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyo-genes and Streptococcus pneumoniae: characterization of South Africa isolates. J Antimicrob Chemother 1998; 42: 729–734.
   PubMed Web of Science ®Google Scholar
• Hamilton-Miller JMT. In vitro activity of 14,-15- and 16-membered macrolides against Gram-positive cocci. J Antimicrob Chemother 1992; 29: 141–147.
   PubMed Web of Science ®Google Scholar
• Somenzi P, Mozzoni P, Benecchi M, Menozzi MG, Ghezzi C. Attivita di rokitamicina vs altri macrolidi a 14, 15 e 16 atomi nell'anello lattonico su batter Gram-positivi isolati a Parma. Bollettino di Microbiologia Industriale e di Laboratorio 1999; 5: 3–7.
   Google Scholar
• Terramocci R and GISPyo group. Sorveglianza della sensibilita di S.pyogenes ai macrolidi ed alle lincosamidi nella pratica quotidiana con l'impiego di Internet. L'Internista 2000; 8: 1–9.
   Google Scholar
• Fujii R. Rokitamycin, a breakthrough in the family of macrolides. [Abstract] 17th ICC, Berlin, Session 97, 1991.
   Google Scholar
• Endou K, Matsuoka M, Nakajima Y. Adhesive binding of rokitamycin to Staphylococcus aureus ribosomes. FEMS Microbiol Lett 1990; 72: 93–96.
   Web of Science ®Google Scholar
• Endou K, Matsuoka M, Taniguchi H, Nakajama Y. Implication of cohesive binding of a macrolide antibiotic, roki-tamycin to ribosomes from Staphylococcus aureus. J Antibiot 1993; 46: 478–485.
   PubMed Web of Science ®Google Scholar
• Leclercq R, Bismuth R. Classification, structure, phar-macocinëtique et mode d'action des macrolides, lincosamides et streptogramines. Phënomënes de resistance. Rev Pract 1988; 38: 1005–1014.
   Google Scholar
• Fernandez-Munoz R, Mouro RE, Torres-Pinedo R, Vazquez D. Substrate- and antibiotic-binding sites at the pep-tidyl-transferase centre of Escherichia coli ribosomes. Studies on the chloramphenicol, lincomycin and erythromycin sites. Eur J Biochem 1971; 22: 185–193.
   Google Scholar
• Aumercier M, le Goffic F. Mechanism of action of the macrolide and streptogramin antibiotics. In: Bryskier AJ, Butzler J-P, Neu H.C, Tulkens PM (eds) Macrolides: chemistry, pharmacology and clinical uses. Oxford: Arnette Blackwell, 1993: 115-123.
   Google Scholar
• Ballesta JPG, Lazaro E. Peptidyltransferase inhibitors: structure-activity relationship analysis by chemical modifica-tion. In: Hill WE, Dahlberg A, Garrett RA, Moore PB, Schlessinger D, Warner JR (eds) The ribosome: structure, functions and evolution. Washington DC: American Society for Microbiology, 1990: 502-510.
   Google Scholar
• Mao JC-H, Putterman M. The intermolecular complex of erythromycin and ribosome. J Mol Biol 1969; 44: 347–361.
   PubMed Web of Science ®Google Scholar
• Brisson-Noël A, Trieu-Cuot P, Courvalin P. Mechanism of action of spiramycin and other macrolides. J Antimicrob Chemother 1988; 22 (Suppl B): 13-23.
   Google Scholar
• Cundliffe E. On the nature of antibiotics binding sites in ribosomes. Biochemie 1987; 69: 863–869.
   PubMed Web of Science ®Google Scholar
• Moazed D., Noller HF. Chloramphenicol, erytromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochemie 1987; 69: 879–884.
   Google Scholar
• Dum W. J., Hansch C. Chemicobiological interactions and the use of partition coefficients in their correlation. Chem Biol Interact 1974; 9: 75–95.
   PubMed Web of Science ®Google Scholar
• Tsuji A, Kubo O, Miyamoto E, Yamana T. Physicochemical properties of I3-lactam antibiotics: oil-water distribution. J Pharm Sci 1977; 66: 1675-1679.
   Google Scholar
• Wildfeuer A, Lemme JD. Zur Pharmakokinetik von Josamycin. Arzneim Forsch/Drug Research 1985; 35: 639–643.
   PubMedGoogle Scholar
• Muto Y, Bandoh K, Watanabe K, Katoh N, Ueno K. Macrolide accumulation by Bacteroides fragilis ATCC 25285. Antimicrob Agents Chemotherapy 1989; 33: 242–244
   PubMed Web of Science ®Google Scholar
• Ohno M, Okta K, Morishita M. Physicochemical prop-erties of rokitamycin. Iyakuhin Kenkyu 1987; 18: 634–639.
   Google Scholar
• Inoue M, Okubo T, Hashimoto H. In vitro antibacterial activity of new macrolide antibiotic, rokitamycin. 28th ICAAC 1988; 904.
   Google Scholar
• Doucet-populaire F, Capobianco JO, Zakula D, Jarlier V, Goldman RC. Molecular basis of clarithromycin activity against Mycobacterium auium and Mycobacterium smegma-tis. J Antimicrob Chemother 1998; 41: 179–187.
   PubMed Web of Science ®Google Scholar
• Goldman RC, Zakula D, Flamm R, Beyer J, Capobianco JO. Tight binding of clarithromycin, its 14-(T)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother 1994; 38: 1496–1500.
   PubMed Web of Science ®Google Scholar
• Mager PP. Electronic and lipophilic interactions of macrolides (leucomycin derivatives) with ribosomal receptor sites. Acta Histochim 1980; 66: 40–43.
   PubMed Web of Science ®Google Scholar
• Di Giambattista M, Vannuffel P, Sunazuka T, Jacob T, Omura S, Cocito C. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes. J Antimicrob Chemother 1986; 18: 307–315.
   PubMed Web of Science ®Google Scholar
• Menninger JR. Functional consequences of binding macrolides to ribosomes. J Antimicrob Chemother 1985; 16: 23–34.
   PubMed Web of Science ®Google Scholar
• Vannuffel P, Cocito C. Mechanism of action of strep-togramins and macrolides. Drugs 1996; 51 (Suppl 1) 1: 20-30.
   Google Scholar
• Mazzei T, Mini E, Novelli A, Periti P. Chemistry and mode of action of macrolides. J Antimicrob Chemother 1993; 31(Suppl): 1-9.
   Google Scholar
• Monzo RE, Vasquez D. Ribosome-catalysed peptidyl transfer: effect of some inhibitors of protein synthesis. J Mol Biol 1967; 28: 161–165.
   PubMed Web of Science ®Google Scholar
• Cerná J, Rychlik I, Pulkzábek P. The effect of antibi-otics on the coded binding of peptidyl-tRNA to the ribosome and on the transfer of the peptidyl residue to puromycin. Eur J Biochem 1969; 9: 27–35.
   PubMedGoogle Scholar
• Vasquez D. Inhibitors of protein synthesis. FESS Lett 1974; 40 (Suppl): S63-S84.
   Google Scholar
• Cundliffe E. Antibiotics and polyribosomes II. Some effects in lincomycin, spiramycin and streptogramin A in vivo. Biochemistry 1969; 8: 2063–2066.
   Google Scholar
• Cundliffe E, Mc Quillen K Bacterial protein synthesis: the effects of antibiotics. J Mol Biol 1967; 30: 137–146.
   PubMed Web of Science ®Google Scholar
• Igarashi K, Ishitsuka H, Kaji A. Comparative studies on the mechanism of action of lincomycin, streptomycin and ery-thromycin. Biochem Biophys Res Commun 1969; 37: 499–504.
   PubMed Web of Science ®Google Scholar
• Ennis HL. Polysome metabolism in Escherichia coli: effects of antibiotics on polysome stability. Antimicrob Agents Chemother 1972; 1: 197–203.
   PubMed Web of Science ®Google Scholar
• Tai PC, Wallace BJ, Davis BD. Selective action of ery-thromycin on initiating ribosomes. Biochemistry 1974; 13: 4653–4659.
   PubMed Web of Science ®Google Scholar
• Menninger JR, Otto DD. Erythromycin, carbomycin and spiramycin inhibit protein synthesis in stimulating the dis-sociation of peptidyl-tRNA from ribosomes. Antimicrob Agents Chemother 1982; 21: 811–818.
   PubMed Web of Science ®Google Scholar
• Andersson S, Kurland CG. Elongating ribosomes in vivo are refractory to erythromycin. Biochimie 1987; 69: 863–869.
   PubMedGoogle Scholar
• Shanson DC. Laboratory control of antimicrobial thera-py. In: O'Grady F, Lambert HP, Finch RG, Greenwood D (eds) Antibiotic and Chemotherapy. New York: Churchill Livingstone, 1997: 137.
   Google Scholar
• Wiedemann B, Grimm H. Susceptibility to antibiotics: species, incidence and trends. In: Lorian V (ed) Antibiotics lab-oratory medicine. Baltimore: Williams & Wilkins 1991: 900.
   Google Scholar
• Hawkey PM. The origins and molecular basis of antibi-otic resistance. Br Med J 1998; 317: 657–660.
   PubMed Web of Science ®Google Scholar
• Martinez JL, Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother 2000; 44: 1771–1777.
   PubMed Web of Science ®Google Scholar
• Davies JE. Origins, acquisition and dissemination of antibiotic resistance determinants. Ciba Foundation Symposium 1997; 207: 15–27.
   PubMedGoogle Scholar
• Mass WK. Mutations to antibiotic resistance. In: Lorian V (ed) Antibiotics in laboratory medicine, 2nd ed. Baltimore: Williams & Wilkins Co. 1986: 669–682.
   Google Scholar
• French GL, Phillips I. Resistance. In: O'Grady F, Lambert HP, Finch RG, Greenwood D (eds), Antibiotic and chemotherapy. New York: Churchill Livingstone, 1997: 32.
   Google Scholar
• Trieu-Cuot P., Arthur M., Courvalin P. Origin, evolu-tion and dissemination of antibiotic resistance genes. Microbiol Sci 1987; 4: 263-266.
   Google Scholar
• Russel AD, Chopra I. Understanding antibacterial action and resistance. New York: Ellis Horwood, 1996: 172.
   Google Scholar
• Mao JC-H, Putterman M. Accumulation in Gram-posi-tive and Gram-negative bacteria as a mechanism of resistance to erythromycin. J Bacteriol 1968; 96: 111–117.
   PubMedGoogle Scholar
• Sutcliffe J, Tait-Kamradt A, Wondrack L. Strepto-coccus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996; 40: 1817–1824.
   PubMed Web of Science ®Google Scholar
• Weisblum B. Inducible resistance to macrolides, lin-cosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity and structural elements that regulate expression. A review. J Antimicrob Chemother 1985; 16 (Suppl A): 63-90.
   Google Scholar
• McGuire JM, Bunch RL, Anderson RC, Boaz HE, Flynn EH, Powerll HM, Smith HW. “Ilotycin”, a new antibiot-ic. Antibiot Chemother 1952; 2: 281–283.
   Google Scholar
• Chabbert YA: Antagonisme in vitro entre l'erithromycin et la spiramycine. Ann Inst Pasteur 1956; 90: 87–90.
   Google Scholar
• Dixon JMS, Lipinski AE. Infections with I3-hemolytic Streptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin. J Infect Dis 1974; 130: 351–356.
   PubMed Web of Science ®Google Scholar
• Horinouchi S, Byeon WH, Weisblum B. A complex attenuator regulates inducible resistance to macrolides, lin-cosamides and streptogramin type B antibiotics in Streptococcus sanguis. J Bacteriol 1983; 154: 1252–1262.
   PubMed Web of Science ®Google Scholar
• Lai CJ, Weisblum B. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Nat Acad Sci, USA 1971; 68: 856–860.
   PubMed Web of Science ®Google Scholar
• Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Road J, Seppala H. Nomenclature for macrolide and macrolide-lin-cosamide-streptogramin B resistance determination. Antimicrob Agents Chemother 1999; 43: 2823–2830.
   PubMed Web of Science ®Google Scholar
• Chabbert YA, Courvalin P. Synergie des composants des antibiotiques de groupe de la streptogramine. Pathol Biol 1971; 19: 613–619.
   PubMedGoogle Scholar
• Arthur M, Brisson-Noël A, Courvalin P Origin and evo-lution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses. J Antimicrob Chemother 1987; 20: 783–802.
   PubMed Web of Science ®Google Scholar
• Oh TG, Lee MJ, Back MC, Kim BK, Choi EC. Resistance to macrolide-lincosamine-streptogramin B antibi-otics is induced by 16 membered-ring macrolide antibiotics in Enterococcus faecalis 373. Arch Pharmacol Res1988; 21: 76.
   Google Scholar
• Weisblum B, Demohn V. Erythromycin-inducible resis-tance in Staphylococcus aureus: survey of antibiotic classes involved. J Bacteriol 1969; 98: 447–452.
   PubMed Web of Science ®Google Scholar
• Duval J. Evolution and epidemiology of MLS resistance. J Antimicrob Chemother 1985; 16 (Suppl A): 137-149.
   Google Scholar
• Kamimiya S Weisblum. Induction of ermSV by 16-membered-ring macrolide antibiotics. Antimicrob Agents Chemother 1997; 41: 530–534.
   PubMed Web of Science ®Google Scholar
• Lacey RW. Evidence for two mechanisms of plasmid transfer in mixed cultures of Staphylococcus aureus in vitro. J Gen Microbiol 1980; 119: 432–435.
   Google Scholar
• Barthelemy P, Antissier D, Gerbaud G, Courvalin P. Enzymatic hydrolysis of erythromycin by a strain of Escherichia coli a new mechanism of resistance. J Antibiot 1984; 37: 1692–1696.
   PubMed Web of Science ®Google Scholar
• O'Hara K, Kanda T, Ohmiya K, Ebisu T, Kono M. Purification of characterization of macrolide 2'-phosphotrans-ferase from a strain of Escherichia coli that is highly resistant to erythromycin. Antimicrob Agents Chemother 1989; 33: 1354–1357.
   PubMed Web of Science ®Google Scholar
• Brisson-Noël A, Delrieu P, Samain D, Courvalin P. Inactivation of lincosaminide antibiotics in Staphylococcus. J Biol Chem 1988; 263: 15880–15887.
   PubMed Web of Science ®Google Scholar
• Le Goffic F, Cap man ML, Abbë J, Cerceau C, Dublanchet A, Duval J. Plasmid-mediated pristinamycin resis-tance: PHIA, a pristinamycin IA hydrolase. Ann Microbiol 1977; 128: 471–474.
   Google Scholar
• Le Goffic F, Capman ML, Bonnet ML, et al. Plasmid-mediated pristinamycin resistance. PACIIA, a new enzyme which modifies pristinamycin IIA. J Antibiot 1977; 30: 665–669.
   Google Scholar
• Clancy J, Petitpas J, Dib-Hajj F, et al. Molecular cloning and functional analysis of a novel macrolide resistance determinant, mef A, from Streptococcus pyogenes. Mol Microbiol 1996; 22: 867–879.
   PubMed Web of Science ®Google Scholar
• Luna VA, Coates P, Eady EA, Cove J, Nguyen TTH, Roberts MC. A variety of Gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother 1999; 44: 19–25.
   PubMed Web of Science ®Google Scholar
• Nishijima T, Saito Y, Aoki A, Toriya M, Toyonaga Y, Fujii R. Distribution of mef E and erm B genes in macrolide-resistant strains of Streptococcus pneumoniae and their vari-able susceptibility to various antibiotics. J Antimicrob Chemother 1999; 43: 637–643.
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Endou K, Kobayashi H, Inoue M, Nakajima Y. A plasmid that encodes three genes for resis-tance to macrolide antibiotics in Staphylococcus aureus. FEMS Microbiol Lett 1998; 167: 221–227.
   PubMed Web of Science ®Google Scholar
• Cornaglia G, Ligozzi M, Mazzariol A, Masala L, Lo Cascio G, Orefici G and the Italian Surveillance Group for Antimicrobial Resistance, and Roberta Fontana. Resistance of Streptococcus pyogenes to erythromycin and related antibi-otics in Italy. Clin Infect Dis 1998; 27 (Suppl 1): S87-S92.
   Google Scholar
• Novick RP, Murphy E. MLS-resistance determinants in Staphylococcus aureus and their molecular evolution. J Antimicrob Chemother 1985; 16 (Suppl A): 101-110.
   Google Scholar
• Goossens H, Sprenger MJW Community acquired infections and bacterial resistance. Br Med J 1998; 317: 654–657.
   PubMed Web of Science ®Google Scholar
• Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Diagnosis and management of group A strepto-coccal pharyngitis: a practice guideline. Clin Infect Dis 1997; 25: 574–583.
   PubMed Web of Science ®Google Scholar
• Kaplan EL. The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis 1991; 10: 55–57.
   PubMed Web of Science ®Google Scholar
• Nakae M, Murai T, Kaneko Y, Mitsuhashi S. Drug resis-tance in Streptococcus pyogenes isolated in Japan. Antimicrob Agents Chemother 1977; 12: 427–428.
   PubMed Web of Science ®Google Scholar
• Bass JW, Weisse ME, Plymyer MR, Murphy S, Eberly BI. Decline of erythromycin resistance of group AP-hemolytic streptococci in Japan. Arch Pediatr Adolesc Med 1994; 148: 67–71.
   PubMedGoogle Scholar
• Sefton AM, Maskall JP, Young F, Chi SJ, William JD. Comparative in vitro activity of A-56268. Eur J Clin Microbiol Infect Dis 1988; 7: 798–802.
   PubMed Web of Science ®Google Scholar
• Jansson L, Kahn M. Comparative in vitro activity of A-56268 against respiratory tract pathogen. Eur J Clin Microbiol 1987; 6: 494–496.
   PubMedGoogle Scholar
• Spencer RC, Wheat PF, Mager JT, Brown EH. Erythromycin resistance in streptococci, Lancet 1989; i: 168.
   Google Scholar
• Perez-Trallero E, Garcia Arenzana JM, Urbieta Egana M. Erythromycin resistance in streptococci. Lancet 1989; ii: 444–445.
   Google Scholar
• Borzani M, Varotto F, Garlaschi L, Conio F, Dell'Olio M, Careddu P. Clinical and microbiological evaluation of mio-camycin activity against group A beta-hemolytic streptococci in pediatric patients. Three years incidence of erythromycin-resistant group A streptococci. J Chemother 1989; 1: 35–38.
   Google Scholar
• Toreci K, Cetin ET, Aug O. Antibiotic susceptibility of 7726 strains isolated from clinical specimens. Curr Chemother 1978; 1: 553–556.
   Google Scholar
• Yamada T, Hakegawa H, Oguri T, Kosakai N. Drug susceptibilityof13-hemolytic streptococci isolated in Japan and other Asian dis-tricts (1975-1977). Curr Chemother 1978; 1: 551–553.
   Google Scholar
• Tadano J, Kosakai N, Oguri T, Wang CM. A study on 13-hemolytic streptococci isolated from the throats of healthy schoolchildren in Taiwan: changing patterns of type distribution and drug susceptibility. Curr Chemother 1978; 1: 547–550.
   Google Scholar
• Saraglon G, Bisno AL. Susceptibility of skin and throat strains of group A streptococci to rosaramycin and ery-thromycin. Antimicrob Agents Chemother 1978; 13: 701–702.
   PubMed Web of Science ®Google Scholar
• Istre GR, Welch DF, Marks MI, Moyer N. Susceptibility of group A beta-haemolytic streptococcus isolates to penicillin and erythromycin. Antimicrob Agents Chemother 1981; 20: 244–246.
   PubMed Web of Science ®Google Scholar
• Dixon JMS, Lipanski E. Occurrence of antibiotic resis-tance in hemolytic streptococci. In: Schlessinger D (ed) Microbiology. Washington DC: American Society for Microbiology, 1982: 147–150.
   Google Scholar
• Shah PM, Bryskier A. Epidemiology of resistance to macrolide antibiotics. In Briskier AJ, Butzler JP, Neu HC, Tulkens PM (eds) Macrolides: chemistry, pharmacology and clinical uses. Oxford: Annette Blackwell, 1993: 143-166.
   Google Scholar
• Warren RE, Haines D, Walpole E, Coles MAT. Erythromycin-resistance Streptococcus pneumoniae. Lancet 1988; ii: 1433.
   Google Scholar
• Phillips G, Parratt D, Orange CV, Harper I, Mc Ewan H, Young N. Erythromycin-resistant Streptococcus pyogenes. J Antimicrob Chemother 1990; 25: 723–724.
   PubMed Web of Science ®Google Scholar
• Stingemore N, Francis GRJ, Toohey M, McGechie DB. The emergence of erythromycin in Streptococcus pyo-genes in Freemantle, Western Australia. Med J Australia 1989; 150: 626–627.
   PubMed Web of Science ®Google Scholar
• Jarvionen H, Nissinen A, Huovinen P. Erythromycin resistance in group A streptococci. Lancet 1989; i: 1022–1023.
   Google Scholar
• Bingen E, Fitoussi F, Doit C, et al. Resistance to macrolides in Streptococcus pyogenes in France in paediatric patients. Antimicrob Agents Chemother 2000; 44: 1453–1457.
   PubMed Web of Science ®Google Scholar
• Laverdiere M, Weiss K, Rivest R, Delorme J. Trends in antibiotic resistance of staphylococci over an eight-year peri-od: differences in the emergence of resistance between coagu-lase positive and coagulase-negative staphylococci. Microb Drug Resist 1998; 4: 119–122.
   PubMed Web of Science ®Google Scholar
• Tzelepi E, Kouppari G, Mavroidi A, Zaphiropoulou A, Tzouvelakis LS. Erythromycin resistance amongst group A 13-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece. J Antimicrob Chemother 1999; 43: 745–746.
   PubMed Web of Science ®Google Scholar
• Barry AL, Fuchs PC, Brozn SD. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyo-genes isolates from out-patients in the USA. J Antimicrob Chemother 1997; 40: 139–140.
   PubMed Web of Science ®Google Scholar
• Kaplan SL. Recent evolution of antimicrobial resistance in I3-haemolytic streptococci. Clin Infect Dis 1997; 24 (Suppl 1): S89–S92.
   PubMedGoogle Scholar
• Sappala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441–446.
   PubMed Web of Science ®Google Scholar
• Kataja Huovinen P, Muotiala A, Vuopio-Varkila J, Esfotration G, Hallas G, The Finnish Study Group for Antimicrobial Resistance, and Sappala H. Clonal spread of group A Streptococcus with the new type of erythromycin-resistance. J Infect Dis 1998; 177: 786–789.
   Google Scholar
• Jasir A, Schalen C. Survey of macrolide-resistance phenotypes in Swedish clinical isolates of Streptococcus pyo-genes. J Antimicrob Chemother 1998; 41: 135–137.
   PubMed Web of Science ®Google Scholar
• Bawer° F, Garcia-Rodriguez JA, Garcia De Lomas J, Aguilar L, and the Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swab in Spain: result of a 1-year (1996-1997) multicentric surveillance study. Antimicrob Agents Chemother 1999; 43: 178–180.
   Google Scholar
• Perez-Trallero E, Marimon JM, Montes JM, Orden B, de Pablos M. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerging Infect Dis 1999; 3: 235–240.
   Google Scholar
• Perez-Trallero E, Urbieta M, Montes M, Ayestaran I, Marimon JM. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol Infect Dis 1998; 17: 25–31.
   PubMed Web of Science ®Google Scholar
• Hsueh PR, Chen HM, Huang AH, Wu JJ. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother 1995; 38: 2239–2242.
   Google Scholar
• Varaldo PE, Costantini M, Debbia EA, and the Artemis Italy Study Group. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in pediatric patients: influence of macrolide resistance on clinical and microbiologi-cal outcomes. Clin Infect Dis 1999; 29: 869–873.
   Google Scholar
• Schito GC, Pesce A, Debbia EA. Razionale microbio-logico per l'uso di antibiotici orali nella terapia delle infezioni respiratorie comunitarie alla luce dell'attuale realta epidemio-logica italiana. Giorn Ital Microbiol Med Odont Clin 1999; 3 (Suppl A): 5A35-5A58.
   Google Scholar
• Schito GC, Pesce A, Marchese A The role of macrolides in Streptococcus pyogenes. J Antimicrob Chemother 1997; 39: 562–565.
   PubMed Web of Science ®Google Scholar
• Scopetti F, Pataracchia M, Pacifico L. A Multicentric study on antimicrobial susceptibility and typing of group A streptococci (GAS) from cases of pharyngo-tonsillitis and scar-let fever. Microecol Ther 1995; 25: 348–355.
   Google Scholar
• Millesimo M, Savoia D. Group A streptococci: evalua-tion on in vitro resistance to two macrolides. Microbios 1995; 82: 141–147.
   PubMedGoogle Scholar
• Cipriani P, Debbia EA, Gesu GP. Indagine policentrica AMCLI sull'incidenza di resistenze agli antibiotici in S. pyo-genes. Microbiol Med 1995; 10: 171–174.
   Google Scholar
• Cristiano L, Bonzi D, Noris C, et al. Streptococchi 13-emolitici di gruppo A: rapido incremento di ceppi resistenti all'eritromicina in un'area del Nord Italia. Microbiol Med 1996; 11: 30–33.
   Google Scholar
• Cornaglia G, Ligozzi M, Mazzariol A,Valentini M, Orefici G, Fontana R. Rapid increase of resistance to ery-thromycin and clindamycin in Streptococcus pyogenes in Italy. 1993-1995. Emerg Infect Dis 1996; 2: 339–342.
   Google Scholar
• Borzani M, De Luca M, Varotto F. A survey of suscep-tibility to erythromycin amongst Streptococcus pyogenes iso-lates in Italy. J Antimicrob Chemother 1997; 40: 457–458.
   PubMed Web of Science ®Google Scholar
• Chelossi E, Platê M, De Leo C, Schito GC. Attivita di alcuni antibiotici su Streptococcus pyogenes isolati recente-mente in Italia. Giorn Ital Microbiol Med Odont Clin 1997; 1: 7–21.
   Google Scholar
• VaraIdo PE, Montanan MP, Ripa S. Secondo progetto Artemis Italia (1998). 2. Risultati microbiologici. Giorn Ital Microbiol Med Odont Clin 1999; 3(QII): 9-14.
   Google Scholar
• Schito GC, Debbia EA, Marinelli S. Secondo progetto Artemis Italia (1998), 5. Discussione e conclusioni. Giorn Ital Microbiol Med Odont Clin 1999; 3(QII): 28-41.
   Google Scholar
• Giovanetti E, Montanan MP, Mingoia M, Varaldo PE. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducible resistant strains. Antimicrob Agents Chemother 1999; 47: 1935–1940.
   Google Scholar
• Chelossi E, Platê M, De Leo C, Schito GC. Analisi genotipica di Streptococcus pyogenes eritromicino-resistenti isolati recentemente in Italia. Giorn Ital Microbiol Med Odont Clin 1998; 2: 9–30.
   Google Scholar
• Garcia-Bermejo I, Cacho J, Orden B, Abs JI, Gomez Garces JL. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. Antimicrob Agents Chemother 1998; 42: 989–990.
   PubMed Web of Science ®Google Scholar
• Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 1997; 24 (Suppl 1): 585–588.
   Google Scholar
• Jacobs MR, Koornhof HJ, Robins-Browne RM, et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978; 299: 735–740.
   PubMed Web of Science ®Google Scholar
• Appelbaum PC, Koornhof HJ, Jacobs M, et al. Multiple-antibiotic resistance in pneumococci in South Africa. MMWR 1977; 26: 285–286.
   Google Scholar
• Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae. An overview. Clin Infect Dis 1992; 15: 77–83.
   PubMed Web of Science ®Google Scholar
• Campbell GD Jr, Silberman R. Drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1998; 26: 1188–1195.
   PubMed Web of Science ®Google Scholar
• Bacquero F, Barrett JF, Courvalin P. Epidemiology and mechanisms of resistance among respiratory tract pathogens. Clin Microbiol Infect 1988; 4 (Suppl 2): 19–26.
   Google Scholar
• Goldstein FW, Acar JF, and the Alexander Project col-laborative group. Antimicrobial resistance among lower respi-ratory tract isolates of Streptococcus pneumoniae results of the 1992-1993 Western Europe and USA collaborative sur-veillance study. J Antimicrob Chemother 1996; 38 (Suppl A): 71-84.
   Google Scholar
• Schito GC, Mannelli S, Pesce A, and the Alexander Project Group. Trends in the activity of macrolide and I3-lac-tam antibiotics and resistance development. J Chemother 1997; 9 (Suppl 3): 18-28.
   Google Scholar
• Ronchetti MP, Merolla R, Brajaksouzian S. Antimicrobial susceptibility of Streptococcus pneumoniae from children attending day-care centers in a central Italian city. Clin Microbiol Infect 1998; 4: 622–626.
   PubMedGoogle Scholar
• Marchese A, Debbia EA, Arvigo A, Pesce A, Schito GC. Susceptibility of Streptococcus pneumoniae strains iso-lated in Italy to penicillin and ten other antibiotics. J Antimicrob Chemother 1995; 36: 833–837.
   PubMed Web of Science ®Google Scholar
• Marchese A, Debbia EA, Pesce A, Schito GC. Comparative activities of amoxycillin and 10 other oral drugs against penicillin-susceptible and resistant Streptococcus pneumoniae strains recently isolated in Italy. Clin Microbiol Infect 1998; 4: 170–173.
   PubMedGoogle Scholar
• Schito GC, Mannelli S, Debbia EA. Osservatorio Epidemiologico Italiano. Analisi del primo anno di monitorag-gio delle resistenze agli antibiotici in Streptococcus pneumo-niae. Giorn Ital Microbiol Med Odont Clin 1998; 2: 15–27.
   Google Scholar
• Schito GC, Mannelli S, Cibrario-Sent M, Pesce A, Marchese A. Osservatorio Epidemiologico Italiano. Patogeni batterici respiratori comunitari e nosocomiali: analisi delle resistenze nel 1997: Streptococcus pneumoniae. Giorn Ital Microbiol Med Odont Clin 1999; 3: 11–24.
   Google Scholar
• Schito GC, Mannelli S, Cibrario-Sent M, Pesce A, Marchese A. Evoluzione delle resistenze ai farmaci antimicrobi-ci in Streptococcus pneumoniae circolante in Italia. Analisi dei dati dell'Osservatorio Epidemiologico Italiano. Giorn Ital Microbiol Med Odont Clin 1999; 3: 43–57.
   Google Scholar
• Marchese A, Tonoli E, Debbia EA, Schito GC. Macrolide resistance mechanisms and expression of pheno-types among Streptococcus pneumoniae circulating in Italy. J Antimicrob Chemother 1999; 44: 461–464.
   PubMed Web of Science ®Google Scholar
• Oster P, Zanchi A, Cresti S, et al. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. Antimicrob Agents Chemother 1999; 43: 2510–2512.
   PubMed Web of Science ®Google Scholar
• Tonoli E, Marchese A, Debbia EA, Schito GC. Prevalence and characterisation of the mechanisms of macrolide resistance in 830 penicillin-susceptibility S. pneu-moniae isolated in Italy during 1993-1997. In: 4th International Conference on the Macrolides, Azalides, Streptogramins and Ketolides. Barcelona 1998; Abs.317.
   Google Scholar
• Lantero M, Portilo A, Gastanares MJ, Ruiz-Larrea F, Zarazaga M, Olarte I. MLS resistance phenotypes and mechanisms in S. pneumoniae. In: 4th International Conference on the Macrolides, Azalides, Streptogramins and Ketolides. Barcelona, Spain 1998; Abs.310.
   Google Scholar
• Johnston NJ, De Azavedo J, Kelener JD, Low DE. Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 1998; 42: 2425–2426.
   PubMed Web of Science ®Google Scholar
• McDougal LK, Tenover FC. Characterisation of macrolide resistance phenotypes in Streptococcus pneumoni-ae. In: Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Canada 1997; Abs C-77b, p 59. Washington DC American Society for Microbiology.,
   Google Scholar
• Courvalin P, Carlier C. Transposable multiple antibiotic resistance in Streptococcus pneumoniae. Mol Gen Genet 1986; 205: 291–297.
   PubMedGoogle Scholar
• Poulsen RL, Knudsen JK, Petersen MB, Fuursted K, Espersen F, Frimodt-Moller N. In vitro activity of six macrolides clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities. APMIS 1996; 104: 227–233.
   PubMed Web of Science ®Google Scholar
• Peacock JE, Moorman DR, Wenzel RP, Mandell GL. Methicillin-resistant Staphylococcus aureus: microbiologic characteristics antimicrobial susceptibilities and assessment of virulence of an epidemic strain. J Infect Dis 1985; 144: 575–582.
   Google Scholar
• Barry AL, Thornsberry C, Jones RN. In vitro activity of new macrolide, A-52268, compared with that of rox-ithromycin, erythromycin and clindamycin. Antimicrob Agents Chemother 1987; 31: 343–345.
   PubMed Web of Science ®Google Scholar
• Rogers M, Dorman DC, Gapes M, Ly J. A three-year study of impetigo in Sydney. Med J Australia 1987; 147: 63–65.
   PubMed Web of Science ®Google Scholar
• Ohams N, Keness J, Verner E, Raz R, Rozenman D, Zuckerman F. Skin-isolated, community-acquired Staphylo-coccus aureus: in vitro resistance to methicillin and ery-thromycin. J Am Acad Dermatol 1989; 21: 544–546.
   PubMed Web of Science ®Google Scholar
• Schito GC, Varaldo PE. Trends in the epidemiology and antibiotic resistance of clinical staphylococcus strains in Italy: a review. J Antimicrob Chemother 1988; 21 (Suppl C): 67-78.
   Google Scholar
• Restelli A, Restelli L, Scarazatti M. Streptococco beta-emolitico di gruppo A (SBEA): sensibilita e resistenze. Congresso su: Immunita ed infezione in pediatria, Milano 1998; Abs.10.
   Google Scholar
• Cocuzza CE, Mattina R, Mazzariol A, et al. High inci-dence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study. Microbiol Drug Resist 1997; 3: 371–378.
   PubMed Web of Science ®Google Scholar
• Piccinini L, Mucci A. Epidemiologia delle resistenze dello Streptococcus pyogenes - SBEA. Stato dell'arte a Modena e provincia. 57° Convegno della sezione TOEMA della SIM. Portonovo (AN) 1998; Abs. 57.
   Google Scholar
• Bruno R, Caldera D, Fabiano A, Lasagna C, Negro C, Neri G. Resistenza ai macrolidi di Streptococcus pyogenes isolati da tamponi faringei. XXVII Congresso Nazionale Associazione Microbiologi Clinici Italiani. Venezia 1998; Abs.G088.
   Google Scholar
• Sartori R, Caola I, Gaino M, Caciaghi P. Resistenza ai macrolidi dei ceppi di Streptococcus pyogenes e di altri strep-tococchi beta-emolitici isolati all'Ospedale S. Chiara di Trento. XXVII Congresso Nazionale Associazione Microbiologi Clinici Italiani. Venezia 1998; Abs.G078.
   Google Scholar
• Mattina R, Rescaldani R, Masera G, Cocuzza CE, Bramati S, Nova A. Valutazione della resistenza dello SBEA ai macrolidi nella faringo-tonsillite in eta pediatrica. Studio di coorte nell'area monzese. “1997 Focus on Streptococcus pyogenes" Milano 1997.
   Google Scholar
• Mattina R. Epidemiologia delle resistenze dello Streptococcus pyogenes: l'esperienza in Lombardia. Settimana Pediatrica Nazionale. Simposio su Streptococcus pyogenes resistente ad eritromicina: come superare 11 proble-ma? Montecatini Terme. Abstract book 1997: 9-10.
   Google Scholar
• Cali AM, Gualdi P, Schinella M. Attivita antibatterica in vitro di alcuni macrolidi su ceppi di Streptococcus pyogenes isolati dal tratto respiratorio. XXVII Congresso nazionale Associazione Microbiologi Clinici Italian'. Venezia 1998; Abs. G087.
   Google Scholar
• Montuori M, Tosi MT, Gandini MC, Sturla C, Soldarini C. Studio di resistenza di Streptococcus pyogenes al macroli-di. XXVII Congresso nazionale Associazione Microbiologi Clinici Italian'. Venezia 1998; Abs.G081.
   Google Scholar
• Cocuzza C, Lanzafame A, Santini L, Perego L, Decarli A, Mattina R. Tentativo di criterio interpretativo per la definizione della sensibilita “in vitro” del batter a rokitamicina. Microbiol Medica 2000; 15: 105.
   Google Scholar
• Sakakibara H, Okekawa O, Fujiwara T, Otani M, Omura S. Acyl derivatives of 16-membered macrolides. I-Synthesis and biological properties of 3"-O-propionyl leu-comycin A5 (TMS-19 Q). J Antibiot 1981; 34: 1001–1010.
   Google Scholar
• Endou K, Endoh S, Matsuoka M, Nakayama Y. Labile 505 ribosome from partial macrolide-resistant Staphylococcus aureus. Biol Pharm Bull 1993; 16: 328–330.
   PubMed Web of Science ®Google Scholar
• Jones RN. Disk diffusion susceptibility testing of macrolides: the interpretative criteria. In: Bryskier AJ, Butzler J-P, Neu HC, Tulkens PM (eds) Macrolides: chemistry, phar-macology, and clinical uses. Oxford: Arnette Blackwell, 1993: 209-215.
   Google Scholar
• Guazzotti GC, Milano F, Caffiero G, Caviglia F. Resistenza di S. pyogenes al macrolidi nell'area vercellese: prime valutazioni. Microbiol Medica 2000; 15: 214.
   Google Scholar
• Waites K, Johnson C, Gray B, Edwards K, Crain M, Benjamin WJr. Use of clindamycin disks to detect macrolide resistance mediated by erm B and mef E in Streptococcus pneumoniae isolated from adults and children. J Clin Microbiol 2000; 38: 1731–1734.
   PubMed Web of Science ®Google Scholar
• Principi N, Marchisio P, and the Italian Group of Streptococcal Resistance to Macrolides Study Group. Incidence of severe streptococcal-related diseases in Italian children in an era of high group A streptococcal resistance to macrolides. J Chemother 1999; 11: 379–384.
   Google Scholar